Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

Subjects:

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. by Xin Zhou (54275)

Immunogenicity results of different vaccination schemes at different time points. by Rima Moghnieh (679199)

Subjects:

Mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Flow diagram of the study. by Yoonjee Cho (15453454)

Subjects:

Baseline characteristics of patients. by Yoonjee Cho (15453454)

Subjects:

Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Subjects:

IR-induced mutation profiles of DNA repair mutants significantly different from wild-type. by Bettina Meier (274833)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

SD and mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Means (and standard deviations) for the past, present and future ratings of the positive and negative TIPI traits with the significance test of the difference between past and pres... by Joanna Gutral (12101779)

Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. by Udaysankar Chockanathan (18510288)

“…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n_C57BL/6 = 305 units from 5 recording sessions, n_APP/PS1 = 180 units from 4 recording sessions). …”

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

HRV parameters at different time points. by Shiying Liu (1569478)

Subjects:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

Point cell model behavior. by Evan Cudone (5768813)

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Pitfalls of merging only considering end-points. by Almiqdad Elzein (13141038)

Participant characteristics (Mean ± SD) for each age group. by Markéta Rygelová (15453112)

Subjects:

Ranking of genotypes according to the ideotype for each trait and the percentage difference (increase or decrease) in relation to cv. M-82. by Herika Paula Pessoa (13254326)

Subjects: